| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 08/31/2011 | CN102169121A New application of human kinase SBK1 (SH3-binding domain kinase 1) |
| 08/31/2011 | CN102168119A Method for preparing diaporthein B and application of diaporthein B to preparation of antitumor medicaments |
| 08/31/2011 | CN102168085A SiRNA for inhibiting expression of miR-130b gene and expression vector and application of siRNA or/and expression vector to preparation of medicament for improving treatment effect of liver cancer |
| 08/31/2011 | CN102168076A An ubiquitin ligase and the application thereof |
| 08/31/2011 | CN102168069A Cell strain capable of inducing and realizing dual-stabilization of P53 expression and construction method and application thereof |
| 08/31/2011 | CN102168068A Method for amplifying V alpha24NKT (Natural Killer T) cells from peripheral blood |
| 08/31/2011 | CN102168058A Anti-tumor targeting engineering bacteria and bacterial agent and method for preparing bacterial agent |
| 08/31/2011 | CN102167812A Pegylated cyclopamine analog and preparation method as well as application thereof |
| 08/31/2011 | CN102167753A Preparation method of oat beta-glucan |
| 08/31/2011 | CN102167744A Human anti-CD20 monoclonal antibody and preparation method and application thereof |
| 08/31/2011 | CN102167743A Human monoclonal antibody against EGFR, preparation method and purpose thereof |
| 08/31/2011 | CN102167742A Human monoclonal antibody against HER2, preparation method and purpose thereof |
| 08/31/2011 | CN102167740A Fully human anti-VEGF (Vascular Endothelial Growth Factor) monoclonal antibody and preparation method as well as application thereof |
| 08/31/2011 | CN102167720A Betulonic acid derivant for restraining differentiation of osteoclast, preparation method thereof and application thereof |
| 08/31/2011 | CN102167718A 16-imidazole substitute-3amine substitute-5 alpha androstane derivatives and preparation method and application thereof |
| 08/31/2011 | CN102167704A Water-soluble porphyrin gold (III) anticancer compounds and preparation method thereof |
| 08/31/2011 | CN102167690A Icariin aglucone derivative and preparation method and application thereof |
| 08/31/2011 | CN102167687A Novel compound, anti-tumor agent, pharmaceutical, food and cosmetic |
| 08/31/2011 | CN102166364A Inhibitor of calcium-independent phospholipase A2 used for treating oophoroma |
| 08/31/2011 | CN102166357A Medicinal composition containing bicyclic aza-alkane derivative |
| 08/31/2011 | CN102166338A Alpinia katsumadai-ginger composite, preparation method thereof and use thereof for preparing toxicity-attenuating and effect-increasing medicine for radiotherapy and chemotherapy of cancer |
| 08/31/2011 | CN102166337A Ginger and inula flower composition as well as preparation method and application thereof in preparation of toxicity reducing and efficacy enhancing medicament in radiotherapy and chemotherapy of cancer |
| 08/31/2011 | CN102166336A Composition of loguat leaves and ginger as well as preparation method and application thereof to preparing toxicity reducing and efficacy enhancing medicines for radiotherapy and chemotherapy of cancers |
| 08/31/2011 | CN102166335A Ginger and long pepper composition as well as preparation method and application thereof in preparation of toxicity reducing and efficacy enhancing medicament in radiotherapy and chemotherapy of cancer |
| 08/31/2011 | CN102166295A Traditional Chinese medicine composition for treating carcinosis |
| 08/31/2011 | CN102166260A Clove extract with tumor resisting effect and pharmaceutical preparation thereof |
| 08/31/2011 | CN102166251A Solid biological medicament for treating stomach cancer, large intestine cancer and alimentary canal diseases |
| 08/31/2011 | CN102166250A Liquid biological medicament for treating esophagus cancer, cardiac cancer and diseases of digestive tract |
| 08/31/2011 | CN102166246A Oil-in-water type atractylis oil nano emulsion oral liquid |
| 08/31/2011 | CN102166245A Oil in water type blumea oil nanoemulsion and preparation method thereof |
| 08/31/2011 | CN102166244A Method for extracting antitumor active substances from field thistles and antitumor field thistle medicament |
| 08/31/2011 | CN102166230A Microwave-assisted extraction method of seaweed polyphenol |
| 08/31/2011 | CN102166228A A method of treating a malignancy in a subject via direct picornaviral-mediated oncolysis |
| 08/31/2011 | CN102166218A Method and composition for treatment of neoplasms |
| 08/31/2011 | CN102166215A Pharmaceutical composition containing piperazine derivatives |
| 08/31/2011 | CN102166196A Local injection-type carboplatin microspheres and method for preparing same |
| 08/31/2011 | CN102166195A Hydroxytyrosol pellets and preparation method thereof |
| 08/31/2011 | CN102166193A Phloretin pellet and preparation method thereof |
| 08/31/2011 | CN102166190A Paclitaxel nano liposomes of dual targeting tumor and method for preparing paclitaxel nano liposomes |
| 08/31/2011 | CN102166189A Target and fluorescence dual-functional slightly-soluble antitumor medicament nano structural lipid carrier |
| 08/31/2011 | CN102166187A Recombinant human endostatin sustained-release injection oil preparation and preparation process thereof |
| 08/31/2011 | CN102166182A Nanometer probe and application thereof in tumor diagnosis composition and photodynamic therapy |
| 08/31/2011 | CN101926916B Chinese medicinal powder for treating tumor |
| 08/31/2011 | CN101897869B Medicament for treating tumor |
| 08/31/2011 | CN101891697B Alpha, beta-unsaturated ketone compound containing 1,2,4-oxadiazoles heterocycle |
| 08/31/2011 | CN101837058B Medicament for curing leukemia |
| 08/31/2011 | CN101797232B Method for preparing small-granularity recombination human vascular endothelium inhibin slowly-released particle for injection |
| 08/31/2011 | CN101780254B Traditional Chinese medicine compound for treating intestinal tumor |
| 08/31/2011 | CN101759675B Method for preparing active sesquiterpenes with functions of cancer resistance and bacterium inhibition from ligularia fischeri |
| 08/31/2011 | CN101757640B Preparation of clathrate compound containing isoflavone and cyclodextrin of chickpea |
| 08/31/2011 | CN101757567B Traditional Chinese medicine composition for treating rectal cancer and preparation method thereof |
| 08/31/2011 | CN101732727B Preparation method of polyamide-amine dendrimer/2-methoxy estradiol compound with terminal functional groups |
| 08/31/2011 | CN101716145B Modified chitosan targeted medicament carrying nano microsphere and preparation method thereof |
| 08/31/2011 | CN101711759B Application of cumarins compound in preparing medicine for inhibiting tumor growth |
| 08/31/2011 | CN101708296B Application of n-butyl alcohol extract of combination of ophiopogon decoction and thousand gold pieces phragmites decoction in preparing medicaments for inhibiting A549 cell proliferation |
| 08/31/2011 | CN101703507B Antineoplastic medicament |
| 08/31/2011 | CN101676295B Method for purifying and separating 2'-deoxidized-2',2'-difluoro nucleotide |
| 08/31/2011 | CN101670090B Pharmaceutical composition for treating intermediate and advanced malignant tumors and pharmaceutical uses thereof |
| 08/31/2011 | CN101669998B Corydalis saxicola pill and preparation method thereof |
| 08/31/2011 | CN101649101B Magnetic nanoparticles with novel nuclear shell structure and pH responsibility as well as application thereof |
| 08/31/2011 | CN101648922B Benzamide histone deacetylase inhibitor and application thereof |
| 08/31/2011 | CN101647842B Fructus Podophylli extract and application thereof |
| 08/31/2011 | CN101612251B Traditional Chinese medicine for treating primary liver cancer |
| 08/31/2011 | CN101607091B Method for synthesizing dextran-magnetic LDH-fluorouracil magnetic targeting sustained and controlled release tripolymer |
| 08/31/2011 | CN101602707B Naphthaline lactam derivative and application thereof in propagation suppression of tumor cells |
| 08/31/2011 | CN101590158B Method for extracting polyphenol from canna edulis ker waste residue |
| 08/31/2011 | CN101584659B Docetaxel medicament composition injection and preparation method thereof |
| 08/31/2011 | CN101439147B Haiqihuang granules as well as preparation method thereof and pharmacy use |
| 08/31/2011 | CN101433720B Tumor-targeted carbon nano-tube medicament carrier and preparation thereof |
| 08/31/2011 | CN101406509B Lonicera confusa extract and preparation method and application thereof |
| 08/31/2011 | CN101395134B 17 beta hsd type 5 inhibitor |
| 08/31/2011 | CN101367871B Snake venom protein component of ahylysantinfarctase at southern Anhui Province, extraction method and uses thereof |
| 08/31/2011 | CN101360709B Tetracyclic indole derivatives as in vivo imaging agents and having peripheralbenzodiazepine receptor affinity (PBR) |
| 08/31/2011 | CN101317832B Oral administration nano-drug administration system of resveratrol |
| 08/31/2011 | CN101306118B Prepared traditional Chinese medicine pill for treating leukemia |
| 08/31/2011 | CN101289482B Cambogic acid glycoside derivates and the like, preparation and uses thereof |
| 08/31/2011 | CN101203489B Oxindole derivatives |
| 08/31/2011 | CN101200469B Separation of regioisomers of metal phthalocyanines |
| 08/31/2011 | CN101167792B Fructus psoralea reverse tumor medicines-resistant active component and preparation method thereof and application |
| 08/31/2011 | CN101157668B Substituted cinnamic acid nitrogen-containing derivative having tumor cytotoxic activity |
| 08/31/2011 | CN101155808B Substituted 1,5-naphthyridine azolidinones as cdk inhibitors |
| 08/31/2011 | CN101080227B Combinations of therapeutic agents for treating cancer |
| 08/30/2011 | US8008437 Prostatic/ovarian tumor antigen for use in diagnosis, prevention and treatment of cell proliferative disorders |
| 08/30/2011 | US8008341 Pharmaceutically active benzsulfonamide derivatives as inhibitors of protein junkinases |
| 08/30/2011 | US8008330 Combinations comprising epothilones and pharmaceutical uses thereof |
| 08/30/2011 | US8008324 Antitumor agents; N-propargyl-N-(2-methyl-6-quinolyl)-[1-(4-chlorobenzyl)indol-3-yl]glyoxylamide |
| 08/30/2011 | US8008322 Substituted pyrazolopyridines, compositions containing them, method for the production thereof, and their use |
| 08/30/2011 | US8008321 Imidazo[1,5-a]pyridin-3-yl)(3-methoxy-4-nitrophenyl)methanone; a and b fibroblast growth factor receptors (FGFR) antagonist; anticarcinogenic, antitumor: lung, breast, prostate, melanomas, gliomas; antiinflammatory, vascular smooth muscle cells: atherosclerosis, restenosis, stent and bypass complications |
| 08/30/2011 | US8008318 39-desmethoxy derivatives of rapamycin |
| 08/30/2011 | US8008310 Derivatives of pyrido[2,3-d]pyrimidine, the preparation thereof, and the therapeutic application of the same |
| 08/30/2011 | US8008308 Phosphonate compounds |
| 08/30/2011 | US8008282 Lipoxin analogs as novel inhibitors of angiogenesis |
| 08/30/2011 | US8008276 Use of zwitterionic polysaccharides for the specific modulation of immune processes |
| 08/30/2011 | US8008266 Nucleic acids containing unmethylated cytosine-guanine dinucleotides activate lymphocytes and redirect an immune response from th2 to th1 |
| 08/30/2011 | US8008077 Photochemical internalization for delivery of molecules into the cytosol |
| 08/30/2011 | US8008076 Method of producing a nucleic acid encoding an antibody |
| 08/30/2011 | US8007810 HLA-A2 tumor associated antigen peptides and compositions |
| 08/30/2011 | US8007799 Vascular endothelial cell growth factor antagonists and uses thereof |
| 08/30/2011 | US8007798 Treatment of complement-associated disorders |
| 08/30/2011 | US8007785 Method for treating colon cancer with tumour-reactive T-lymphocytes |